Soluble epidermal growth factor receptor isoforms in non-small cell lung cancer tissue and in blood

Lung Cancer

Volumn 76, Issue 3, 2012, Pages 332-338

  Maramotti, Sally ^a   Paci, Massimiliano ^a   Miccichè, Francesca ^b   Ciarrocchi, Alessia ^a   Cavazza, Alberto ^a   De Bortoli, Maida ^b   Vaghi, Elena ^b   Formisano, Debora ^a   Canovi, Laura ^a   Sgarbi, Giorgio ^a   Bongarzone, Italia ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Isoforms, Isoelectric point; Non small cell lung cancer; Shedding, OFFGEL electrophoresis; Soluble epidermal growth factor receptor

Indexed keywords

BETA ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; CYTOPLASM; ELECTROPHORESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LUNG NON SMALL CELL CANCER; PRECANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEOMICS; WESTERN BLOTTING;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; HUMANS; LUNG; LUNG NEOPLASMS; PROTEIN ISOFORMS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84860507315     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.11.018     Document Type: Article

References (25)

1. Cohen P. The role of protein phosphorylation in human health and disease. Eur J Biochem 2001, 268:5001-5010.
2. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001, 411:355-365.
3. Ethier S.P. Signal transduction pathways: the molecular basis for targeted therapies. Semin Radiat Oncol 2002, 12:3-10.
4. Salomon D.S., Brandt R., Ciardiello F., Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995, 19:183-232.
5. Herbst R.S., Langer C.J. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin Oncol 2002, 29:27-36.
6. Nicholas M.K., Lukas R.V., Jafri N.F., Faoro L., Salgia R. Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 2006, 12:7261-7270.
7. Bei R., Budillon A., Masuelli L., Cereda V., Vitolo D., Di Gennaro E., et al. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. J Pathol 2004, 204:317-325.
8. Pavelic K., Banjac Z., Pavelic J., Spaventi S. Evidence for a role of Egf receptor in the progression of human lung-carcinoma. Anticancer Res 1993, 13:1133-1138.
9. Hirsch F.R., Varella-Garcia M., Bunn P.A., Di Maria M.V., Veve R., Bremmes R.M., et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003, 21:3798-3807.
10. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994, 300(Pt 2):281-290.
11. Ancot F., Foveau B., Lefebvre J., Leroy C., Tulasne D. Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity. Oncogene 2009, 28(22):2185-2195.
12. Lafky J.M., Wilken J.A., Baron A.T., Maihle N.J. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 2008, 1785:232-265.
13. Perez-Torres M., Valle B.L., Maihle N.J., Negron-Vega L., Nieves-Alicea R., Cora E.M. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Exp Cell Res 2008, 314:2907-2918.
14. Baron A.T., Cora E.M., Lafky J.M., Boardman C.H., Buenafe M.C., Rademaker A., et al. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2003, 12:103-113.
15. Baron A.T., Wilken J.A., Haggstrom D.E., Goodrich S.T., Maihle N.J. Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer. IDrugs 2009, 12:302-308.
16. Sasaki H., Yukiue H., Mizuno K., Sekimura A., Konishi A., Yano M., et al. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Int J Clin Oncol 2003, 8:79-82.
17. Lemos-Gonzalez Y., Rodriguez-Berrocal F.J., Cordero O.J., Gomez C., Páez de la Cadena M. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br J Cancer 2007, 96:1569-1578.
18. Pellegrini R., Centis F., Martignone S., Mastroianni A., Tagliabue E., Tosi E., et al. Characterization of a monoclonal-antibody directed against the epidermal growth-factor receptor-binding site. Cancer Immunol Immunother 1991, 34:37-42.
19. Ros A., Faupel M., Mees H., van Oostrum J., Ferrigno R., Reymond F., et al. Protein purification by Off-Gel electrophoresis. Proteomics 2002, 2:151-156.
20. Pereboeva L., Komarova S., Roth J., Ponnazhagan S., Curiel D.T., Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus. Gene Ther 2007, 14:627-637.
21. Sanderson M.P., Keller S., Alonso A., Riedle S., Dempsey P.J., Altevogt P. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion. J Cell Biochem 2008, 103:1783-1797.
22. Jankovic M.M., Milutinovic B.S. Glycoforms of CA125 antigen as a possible cancer marker. Cancer Biomark 2008, 4:35-42.
23. Baron A.T., Lafky J.M., Connolly D.C., Peoples J., O'Kane D.J., Suman V.J., et al. A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera. J Immunol Methods 1998, 219:23-43.
24. Carney W.P. Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers. Expert Rev Mol Diagn 2007, 7:309-319.
25. Jantus-Lewintre E., Sirera R., Cabrera A., Blasco A., Caballero C., Iranzo V., et al. Clin Lung Cancer 2011, 12(5):320-327.